ATA288376A - Verfahren zur herstellung des neuen 6-chlor-2- (1'-piperazinyl)-pyrazins, seiner n-oxide und seiner salze - Google Patents

Verfahren zur herstellung des neuen 6-chlor-2- (1'-piperazinyl)-pyrazins, seiner n-oxide und seiner salze

Info

Publication number
ATA288376A
ATA288376A AT762883A AT288376A ATA288376A AT A288376 A ATA288376 A AT A288376A AT 762883 A AT762883 A AT 762883A AT 288376 A AT288376 A AT 288376A AT A288376 A ATA288376 A AT A288376A
Authority
AT
Austria
Prior art keywords
pyrazine
piperazinyl
chlorine
oxides
salts
Prior art date
Application number
AT762883A
Other languages
English (en)
Other versions
AT353795B (de
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ATA288376A publication Critical patent/ATA288376A/de
Application granted granted Critical
Publication of AT353795B publication Critical patent/AT353795B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT288376A 1975-04-21 1976-04-20 Verfahren zur herstellung des neuen 6-chlor-2- (1'-piperazinyl)-pyrazins, seiner n-oxide und seiner salze AT353795B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57005275A 1975-04-21 1975-04-21

Publications (2)

Publication Number Publication Date
ATA288376A true ATA288376A (de) 1979-05-15
AT353795B AT353795B (de) 1979-12-10

Family

ID=24277994

Family Applications (1)

Application Number Title Priority Date Filing Date
AT288376A AT353795B (de) 1975-04-21 1976-04-20 Verfahren zur herstellung des neuen 6-chlor-2- (1'-piperazinyl)-pyrazins, seiner n-oxide und seiner salze

Country Status (36)

Country Link
JP (1) JPS51136688A (de)
AR (1) AR210349A1 (de)
AT (1) AT353795B (de)
AU (1) AU496854B2 (de)
BE (1) BE840904A (de)
BG (1) BG34185A3 (de)
CA (1) CA1059128A (de)
CH (1) CH619462A5 (de)
CS (1) CS195726B2 (de)
CY (1) CY1090A (de)
DD (1) DD124599A5 (de)
DE (1) DE2617205C3 (de)
DK (1) DK143899C (de)
EG (1) EG12387A (de)
ES (4) ES447150A1 (de)
FI (1) FI62666C (de)
FR (1) FR2308367A1 (de)
GB (1) GB1492528A (de)
GR (1) GR59900B (de)
HK (1) HK60380A (de)
HU (1) HU172684B (de)
IE (1) IE42979B1 (de)
IL (1) IL49391A (de)
KE (1) KE3088A (de)
LU (1) LU74795A1 (de)
MY (1) MY8100225A (de)
NL (1) NL167692C (de)
NO (1) NO146599C (de)
PH (1) PH12274A (de)
PL (1) PL99664B1 (de)
PT (1) PT65027B (de)
RO (1) RO73278A (de)
SE (1) SE421695B (de)
SU (1) SU638260A3 (de)
YU (1) YU100676A (de)
ZA (1) ZA762320B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4091098A (en) * 1977-04-25 1978-05-23 Merck & Co., Inc. 3-(1-PIPERAZINYL)-1,2,4-BENZOTRIAZINES AND N-oxides
US4163849A (en) 1978-03-17 1979-08-07 Merck & Co., Inc. Piperazinylpyrazines
US4252816A (en) * 1979-12-03 1981-02-24 Merck & Co., Inc. Tetrahydro-1H-1,4-diazepino(1,7-a)benzimidazoles useful as analgesic agents
US4339579A (en) 1980-12-29 1982-07-13 American Home Products Corporation 2,6-Bis-(pyrrolopyrazinyl)pyrazines
EP0094498A3 (de) * 1982-05-06 1985-04-03 American Cyanamid Company Antiarteriosklerotische 1-Piperazin-Derivate
US4547505A (en) * 1983-03-25 1985-10-15 Degussa Aktiengesellschaft N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production
US4788290A (en) * 1987-12-11 1988-11-29 American Home Products Corporation Serotonergic pyrazine derivatives
EP0580465A1 (de) * 1992-06-25 1994-01-26 Sanofi Neue therapeutische Verwendung von heterocyclischen Piperazinen als 5-HT3-Agonisten und neue Derivaten
ATE491689T1 (de) * 1997-10-27 2011-01-15 Neurosearch As Heteroaryl diazacycloalkane als cholinergische ligande für nikotin-acetylcholin-rezeptoren
AU773830B2 (en) * 1999-04-26 2004-06-10 Neurosearch A/S Heteroaryl diazacycloalkanes, their preparation and use
KR20030031886A (ko) * 2000-02-16 2003-04-23 뉴로젠 코포레이션 치환된 아릴피라진
US6825198B2 (en) * 2001-06-21 2004-11-30 Pfizer Inc 5-HT receptor ligands and uses thereof
SE0202287D0 (sv) * 2002-07-19 2002-07-19 Biovitrum Ab New compounds
ATE353693T1 (de) 2002-07-19 2007-03-15 Biovitrum Ab Neue piperazinyl-pyrazinon-derivate zur behandlung von 5-ht2a rezeptor-bedingten erkrankungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2606906A (en) * 1948-10-14 1952-08-12 American Cyanamid Co 1-(2-pyridyl) piperazine and process of preparing same

Also Published As

Publication number Publication date
CS195726B2 (en) 1980-02-29
FR2308367A1 (fr) 1976-11-19
RO73278A (ro) 1982-09-09
AU1296676A (en) 1977-10-20
HK60380A (en) 1980-11-07
DE2617205C3 (de) 1981-01-29
AR210349A1 (es) 1977-07-29
HU172684B (hu) 1978-11-28
IE42979L (en) 1976-10-21
NL7603800A (nl) 1976-10-25
KE3088A (en) 1980-11-07
SU638260A3 (ru) 1978-12-15
DD124599A5 (de) 1977-03-02
MY8100225A (en) 1981-12-31
GB1492528A (en) 1977-11-23
LU74795A1 (de) 1977-02-07
CY1090A (en) 1980-12-27
IL49391A0 (en) 1976-06-30
BE840904A (fr) 1976-08-16
CH619462A5 (en) 1980-09-30
ES459406A1 (es) 1978-08-16
DK164476A (da) 1976-10-22
ES459407A1 (es) 1978-08-16
ES447150A1 (es) 1977-09-16
EG12387A (en) 1978-12-31
BG34185A3 (en) 1983-07-15
PH12274A (en) 1978-12-12
DE2617205A1 (de) 1976-10-28
AT353795B (de) 1979-12-10
DK143899C (da) 1982-04-13
DK143899B (da) 1981-10-26
NL167692C (nl) 1982-01-18
SE7604093L (sv) 1976-10-22
AU496854B2 (en) 1978-11-02
NO146599B (no) 1982-07-26
FI62666B (fi) 1982-10-29
FR2308367B1 (de) 1979-09-21
YU100676A (en) 1982-08-31
FI62666C (fi) 1983-02-10
ES459405A1 (es) 1978-08-16
PT65027A (en) 1976-05-01
CA1059128A (en) 1979-07-24
GR59900B (en) 1978-03-16
NO761207L (de) 1976-10-22
JPS5522475B2 (de) 1980-06-17
JPS51136688A (en) 1976-11-26
PL99664B1 (pl) 1978-07-31
NO146599C (no) 1982-11-03
ZA762320B (en) 1977-11-30
NL167692B (nl) 1981-08-17
SE421695B (sv) 1982-01-25
FI760978A (de) 1976-10-22
DE2617205B2 (de) 1980-05-08
PT65027B (en) 1978-04-03
IE42979B1 (en) 1980-11-19
IL49391A (en) 1979-09-30

Similar Documents

Publication Publication Date Title
ATA800876A (de) Verfahren zur herstellung von neuen 2-phenyl-3- aroylbenzothiophenen und 2-phenyl-3- -aroylbenzothiophen-1-oxiden und von deren salzen
AT361912B (de) Verfahren zur herstellung von neuen heterocyclischen 1-aryloxy-2-hydroxy-3- alkylenaminopropanen und deren salzen
AT363491B (de) Verfahren zur herstellung von neuen 1,3,8trisubstituierten xanthinen und deren salzen
AT353795B (de) Verfahren zur herstellung des neuen 6-chlor-2- (1'-piperazinyl)-pyrazins, seiner n-oxide und seiner salze
AT360034B (de) Verfahren zur herstellung von neuen substi- tuierten 6-phenyl-1,2,4-triazolo-(4,3-b)pyri- dazinen und deren salzen
AT359064B (de) Verfahren zur herstellung von neuen 1h- -pyrazolo (3,4-b)-pyridinen und deren saeure- additionssalzen
AT347952B (de) Verfahren zur herstellung von neuen 1,1,1- triarylalkylaminen und deren salzen
AT355018B (de) Verfahren zur herstellung von neuen 1,2- benzisothiazolinonen und von deren salzen
ATA43078A (de) Verfahren zur herstellung von neuen imidazo- (1,2-a)-chinolin-derivaten und ihren salzen
AT345846B (de) Verfahren zur herstellung des neuen 4-imino- 1.3-diazabicyclo- (3.1.0)-hexan-2-on und seiner physiologisch vertraeglichen salze
AT378958B (de) Verfahren zur herstellung von neuen derivaten des 1,4-chinolyl-2-(4-piperidyl)-aethanols oder des 1,4-chinolyl-3-(4-piperidyl)-propanols und deren salzen
AT351025B (de) Verfahren zur herstellung von neuen 1,4-dihydro -pyridinen und deren salzen
AT342034B (de) Verfahren zur herstellung von neuen 4,4-diphenyl-2-hydroxybutylaminen und ihren salzen
AT357144B (de) Verfahren zur herstellung von neuen 1-acyl-2- hydroxy-1,3-diaminopropanen und deren salzen
AT359070B (de) Verfahren zur herstellung von neuen 2,4-diamino -5-benzylpyrimidinen und deren salzen
AT344886B (de) Verfahren zur herstellung des neuen fortimicin c und seiner salze
AT358588B (de) Verfahren zur herstellung von neuen 1,2,3,4- -tetrahydroisochinolinen und deren salzen
AT350575B (de) Verfahren zur herstellung des neuen 1- (4- fluor-3-triflourmethylthio-phenyl)-piperazin und seiner saeureadditionssalze
AT353274B (de) Verfahren zur herstellung von 2-substituierten 1,4-benzodiazepinen und deren saeureadditions- verbindungen
AT349482B (de) Verfahren zur herstellung von neuen morpholinderivaten, ihren n-oxiden und salzen
ATA670977A (de) Verfahren zur herstellung des neuen n-6-chlor- nicothinoyl-d,1-homocysteinthiolactons und dessen salzen
AT363476B (de) Verfahren zur herstellung von neuen 5,6-dihydro-imidazo(5,1-a)isochinolin-derivaten und ihren salzen
AT357148B (de) Verfahren zur herstellung von neuen 2,3-dihydro -2-oxo-thiophenderivaten und ihren salzen
AT356654B (de) Verfahren zur herstellung von substituierten 6- -aryl-4h-s-triazolo-(3,4-c)-thieno-(2,3-e)-1,4- -diazepinen und deren salzen
AT356293B (de) Verfahren zur herstellung von neuen d-6-alkyl-8 -zyanmethylergolinen-i und deren salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELA Expired due to lapse of time